Core-Oli-T AB: Development of monoclonal antibodies with diagnostic and therapeutic applicability
Here we answer common questions to help you understand our products and services within diagnostics and treatment of Parkinson’s disease.
What are monoclonal antibodies and how are they used?
Monoclonal antibodies are laboratory-made proteins that bind specifically to target proteins and are used in the diagnosis and treatment of Parkinson’s disease.
How can the antibodies developed by Core-Oli-T AB:s aid in the fight against Parkinson’s disease?
By using our antibodies the aim is to enable early diagnosis and support the development of targeted treatments for Parkinson’s disease.
Why is early diagnosis important in Parkinson’s disease?
Early detection of Parkinson’s disease can improve treatment outcomes and quality of life for patients.
How can I contact you for more information?
Contact us via email or phone for help with product information and services that we can provide.
Ground-breaking monoclonal antibodies against Parkinson’s disease
Core-Oli-T AB is dedicated to developing advanced antibody solutions that improve diagnostics and treatment of Parkinson’s disease. Our vision is to drive innovation in life science to improve patients’ quality of life and support medical research.
To drive innovation in Parkinson diagnostics and treatments
Custom-made monoclonal antibodies
Our antibodies enable early detection of Parkinson’s disease and aims to provide precision diagnostic tools for the doctors to increase more efficient treatment outcomes.
Effective tests with biomarkers
Our goal is to develop assays that minimize misdiagnoses and speed up the start of treatment.
Innovative diagnosis
We aim to provide a portfolio of antibodies that can act as arrays to differentiate between neurodegenerative disease symptoms.